COMPOSITIONS COMPRISING IBRUTINIB AND AN ALKALOID HAVING ENHANCED BIOAVAILABILITY

• 收藏
• 分享

专利权人:

CIPLA LIMITED

发明人:

Geena MALHOTRA

申请号：

US16648727

公开号：

US20200268761A1

申请日:

2018.09.19

申请国别(地区):

US

年份:

2020

代理人:

摘要：

A pharmaceutical composition is provided for the treatment of B-cell proliferative disorders. The composition comprises a therapeutically effective amount of ibrutinib and a therapeutically effective amount of at least one alkaloid or derivative thereof. Methods and kits are also provided.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/